Your browser is no longer supported. Please, upgrade your browser.
Settings
CLSN Celsion Corporation daily Stock Chart
CLSN [NASD]
Celsion Corporation
Index- P/E- EPS (ttm)-0.86 Insider Own1.00% Shs Outstand25.80M Perf Week114.18%
Market Cap68.58M Forward P/E- EPS next Y-0.23 Insider Trans2.25% Shs Float- Perf Month158.12%
Income-19.50M PEG- EPS next Q-0.11 Inst Own13.90% Short Float- Perf Quarter160.34%
Sales0.50M P/S137.17 EPS this Y-14.20% Inst Trans- Short Ratio0.10 Perf Half Y128.79%
Book/sh0.63 P/B4.79 EPS next Y57.90% ROA-48.40% Target Price- Perf Year43.81%
Cash/sh0.69 P/C4.40 EPS next 5Y- ROE-120.10% 52W Range0.69 - 3.28 Perf YTD76.61%
Dividend- P/FCF- EPS past 5Y47.50% ROI-76.80% 52W High-7.93% Beta2.06
Dividend %- Quick Ratio2.50 Sales past 5Y0.00% Gross Margin- 52W Low339.91% ATR0.29
Employees29 Current Ratio2.50 Sales Q/Q0.00% Oper. Margin- RSI (14)92.59 Volatility31.55% 13.68%
OptionableYes Debt/Eq0.61 EPS Q/Q-58.10% Profit Margin- Rel Volume14.57 Prev Close3.03
ShortableYes LT Debt/Eq0.47 EarningsMay 15 BMO Payout- Avg Volume1.00M Price3.02
Recom1.80 SMA20106.67% SMA50158.75% SMA200107.91% Volume11,643,597 Change-0.33%
Oct-04-17Upgrade Maxim Group Hold → Buy $7
Apr-10-17Resumed Rodman & Renshaw Buy $1.50
Nov-10-16Downgrade Maxim Group Buy → Hold
Jul-12-16Resumed H.C. Wainwright Buy $3
Jan-19-16Reiterated Maxim Group Buy $12 → $9
Jul-15-15Initiated Maxim Group Buy $12
Jan-10-14Resumed HC Wainwright Buy $5 → $8
Aug-16-12Reiterated Griffin Securities Buy $10 → $18
Feb-16-12Initiated Brean Murray Buy $7
Oct-26-11Initiated Rodman & Renshaw Mkt Outperform $6
Nov-11-09Initiated Needham Buy $7
May-15-20 08:00AM  Celsion Corporation Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
May-08-20 09:00AM  Celsion Corporation to Hold First Quarter 2020 Financial Results Conference Call on Friday, May 15, 2020 GlobeNewswire
Apr-23-20 08:30AM  Celsion Receives $2.5 Million in Non-Dilutive Funding from the Sale of its New Jersey State Net Operating Losses and Grant Funding Under the Paycheck Protection Program GlobeNewswire +6.25%
Apr-17-20 10:04AM  If You Had Bought Celsion (NASDAQ:CLSN) Stock Five Years Ago, You'd Be Sitting On A 97% Loss, Today Simply Wall St.
Apr-15-20 08:30AM  Celsion Reports that Sufficient Events Have Been Reached for the Second Interim Analysis of the Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer GlobeNewswire +6.36%
Apr-04-20 06:13AM  Edited Transcript of CLSN earnings conference call or presentation 26-Mar-20 3:00pm GMT Thomson Reuters StreetEvents
Mar-26-20 09:00AM  Celsion Corp. to Host Earnings Call ACCESSWIRE -7.01%
08:00AM  Celsions OVATION 1 Study with GEN-1 in Ovarian Cancer Shows Strong Progression-Free Survival Treatment Effect Utilizing Medidata Synthetic Control Arm GlobeNewswire
Mar-25-20 04:15PM  Celsion Corporation Reports 2019 Financial Results and Provides Business Update GlobeNewswire +8.74%
Mar-23-20 08:00AM  Celsions GEN-1 Immunotherapy Receives Orphan Drug Designation from the European Medicines Agency GlobeNewswire +19.75%
Mar-19-20 08:30AM  Celsion Corporation to Hold Year-End 2019 Financial Results Conference Call on Thursday, March 26, 2020 GlobeNewswire +10.63%
08:00AM  Celsion Announces Highly Encouraging Initial Clinical Results from the Phase I Portion of the Phase I/II OVATION 2 Study with GEN-1 in Patients with Advanced Ovarian Cancer GlobeNewswire
Mar-03-20 08:30AM  Celsion CEO Issues Letter to Stockholders GlobeNewswire
Feb-28-20 08:45AM  Celsion Corporation Prices $4.8 Million Registered Direct Offering GlobeNewswire -16.13%
Feb-25-20 06:20AM  When Can We Expect A Profit From Celsion Corporation (NASDAQ:CLSN)? Simply Wall St. -9.38%
Feb-06-20 09:25AM  Celsion Corporation Announces DSMB has Confirmed Initial Safety of Weekly GEN-1 Dosing at 100 mg/m² in 15 Randomized Patients with Advanced Ovarian Cancer GlobeNewswire
Feb-04-20 08:30AM  Principal Investigator Professor Riccardo Lencioni Presents Celsion ThermoDox® Trial Data at SPECTRUM 2020 Interventional Oncology Conference GlobeNewswire
Jan-20-20 05:41AM  Does Celsion Corporation (NASDAQ:CLSN) Have A High Beta? Simply Wall St.
Jan-15-20 04:34PM  Alexion to Start Pivotal Study on Ultomiris for ALS in Q1 Zacks
08:22AM  Momenta (MNTA) Provides Pipeline Updates, Stock Rallies Zacks
Jan-14-20 08:53AM  Ultragenyx Provides Preliminary Crysvita 2019 Revenues Zacks
Jan-09-20 04:47PM  Applied Therapeutics Up on Positive Galactosemia Study Data Zacks
Jan-07-20 09:59AM  Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder Zacks
09:19AM  aTyr (LIFE) Surges on Collaboration Deal With Kyorin Pharma Zacks
Dec-23-19 02:15PM  Hedge Funds Have Never Been This Bullish On Celsion Corporation (CLSN) Insider Monkey
Dec-18-19 08:00AM  Celsions New Subsidiary in China to Serve as Beachhead for Commercializing ThermoDox® in China and Southeast Asia GlobeNewswire -6.67%
Dec-17-19 08:00AM  Celsion Receives $2.0 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program GlobeNewswire
Dec-15-19 08:10AM  Should You Be Pleased About The CEO Pay At Celsion Corporation's (NASDAQ:CLSN) Simply Wall St.
Nov-30-19 01:48AM  Edited Transcript of CLSN earnings conference call or presentation 15-Nov-19 4:00pm GMT Thomson Reuters StreetEvents
Nov-14-19 04:05PM  Celsion Corporation Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire +28.69%
08:00AM  Celsion Announces Publication of Research on Fluorescence Imaging of ThermoDox® Uptake in International Journal of Hyperthermia GlobeNewswire
Nov-09-19 08:40AM  If You Had Bought Celsion (NASDAQ:CLSN) Stock Five Years Ago, You'd Be Sitting On A 96% Loss, Today Simply Wall St.
Nov-08-19 08:30AM  Celsion Corporation to Hold Third Quarter 2019 Financial Results Conference Call on Friday, November 15, 2019 GlobeNewswire
Nov-05-19 08:00AM  Celsion Announces DSMB Recommendation to Continue GEN-1 at 100mg/m² Dose to Complete the Phase I Portion of OVATION 2 Study in Ovarian Cancer GlobeNewswire -9.20%
Nov-04-19 08:00AM  Celsion Reports Unanimous Independent Data Monitoring Committee Recommendation to Continue the Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer GlobeNewswire
Oct-04-19 07:52AM  Is Celsion (NASDAQ:CLSN) Using Debt In A Risky Way? Simply Wall St.
Oct-01-19 08:00AM  Celsion Strengthens Its 2019 Balance Sheet with the Approval of Its Application to Sell Net Operating Losses for $2.1 Million in Non-Dilutive Funding GlobeNewswire
Sep-30-19 02:30PM  Celsion to Present at the Chardan 3rd Annual Genetic Medicines Conference GlobeNewswire
Sep-23-19 08:00AM  Celsion Co-sponsors Hepatocellular Carcinoma Symposium at the International Liver Cancer Association (ILCA) Annual Conference GlobeNewswire
Sep-04-19 06:32AM  Market Sentiment Around Loss-Making Celsion Corporation (NASDAQ:CLSN) Simply Wall St.
Aug-27-19 08:00AM  Celsion Announces Publication of Findings from Single-Site Study in China of ThermoDox® Plus RFA in the Journal of Cancer Research and Therapeutics GlobeNewswire
Aug-23-19 05:40AM  Edited Transcript of CLSN earnings conference call or presentation 15-Aug-19 3:00pm GMT Thomson Reuters StreetEvents
Aug-14-19 04:30PM  Celsion Corporation Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Aug-13-19 08:01AM  Celsion Announces Publication of Results of National Institutes of Health (NIH) Analysis of ThermoDox® in Journal of Vascular and Interventional Radiology GlobeNewswire
Aug-09-19 08:30AM  Celsion's GEN-1 Immunotherapy Highlighted in Oppenheimer's Expert Call on Ovarian Cancer Treatment Landscape and Emerging Opportunities GlobeNewswire
Aug-08-19 08:30AM  Celsion Corporation to Hold Second Quarter 2019 Financial Results Conference Call on Thursday, August 15, 2019 GlobeNewswire
Aug-06-19 10:30AM  Will Celsion (CLSN) Report Negative Q2 Earnings? What You Should Know Zacks
Aug-05-19 09:00AM  Celsion Announces Data Lock for First Interim Analysis in OPTIMA Phase III Study of ThermoDox® in Primary Liver Cancer GlobeNewswire
07:31AM  Before You Buy Celsion Corporation (NASDAQ:CLSN), Consider Its Volatility Simply Wall St.
Jun-20-19 08:30AM  Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox® Plus High Intensity Focused Ultrasound in Breast Cancer Patients at University Medical Center Utrecht in the Netherlands GlobeNewswire
May-29-19 04:17AM  Edited Transcript of CLSN earnings conference call or presentation 15-May-19 3:00pm GMT Thomson Reuters StreetEvents
May-15-19 09:00AM  Celsion Corp. to Host Earnings Call ACCESSWIRE +6.07%
08:00AM  Celsion Corporation Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
May-13-19 09:30AM  Is Celsion (CLSN) Stock Outpacing Its Medical Peers This Year? Zacks
08:44AM  Blueprint Medicines (BPMC) Q1 Earnings & Sales Lag Estimates Zacks
May-10-19 10:11AM  Spectrum Pharma (SPPI) Q1 Earnings Lag Estimates, Revenues Nil Zacks
10:00AM  Puma Biotech (PBYI) Q1 Earnings Top, Nerlynx Disappoints Zacks
May-09-19 03:03PM  IVERIC bio's (ISEE) Q1 Loss Narrows, Gene Therapy in Focus Zacks
11:05AM  Sarepta (SRPT) Q1 Earnings Top Estimates, Exondys 51 Sales Up Zacks
09:03AM  Arena Pharmaceuticals' (ARNA) Loss Widens in Q1 But Stock Up Zacks
May-08-19 05:00PM  Celsion Corporation to Hold First Quarter 2019 Financial Results Conference Call on Wednesday, May 15, 2019 GlobeNewswire
10:30AM  Will Celsion (CLSN) Report Negative Earnings Next Week? What You Should Know Zacks
May-07-19 05:50PM  Celsion (CLSN) Dips More Than Broader Markets: What You Should Know Zacks
May-01-19 05:50PM  Celsion (CLSN) Flat As Market Sinks: What You Should Know Zacks
Apr-26-19 11:11AM  Medicines Company (MDCO) Q1 Loss Narrows, Inclisiran in Focus Zacks -5.73%
10:59AM  AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales Zacks
09:30AM  Is Celsion (CLSN) Outperforming Other Medical Stocks This Year? Zacks
Apr-25-19 09:31AM  Alexion (ALXN) Q1 Earnings Beat Estimates, Guidance Raised Zacks
Apr-17-19 08:14AM  Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA Zacks
08:00AM  Celsion Corporation Announces Issuance of New Patent for ThermoDox® GlobeNewswire
Apr-16-19 07:26PM  ProQR Initiates Dosing in Phase II/III Eye Disorder Study Zacks
Apr-12-19 08:30AM  Celsion Corporation to Participate in Two Investor Conferences in May 2019 GlobeNewswire
08:00AM  Celsion Corporation to Hold First Quarter 2019 Financial Results Conference Call on Wednesday, May 15, 2019 GlobeNewswire
Apr-11-19 12:34PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Celsion Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Apr-08-19 08:43AM  Edited Transcript of CLSN earnings conference call or presentation 29-Mar-19 3:00pm GMT Thomson Reuters StreetEvents
Apr-03-19 09:00AM  Celsion (CLSN) Moves to Strong Buy: Rationale Behind the Upgrade Zacks +17.56%
Mar-29-19 08:00AM  Celsion Corporation Reports 2018 Financial Results GlobeNewswire
Mar-22-19 08:30AM  Celsion Corporation to Hold Year-End 2018 Financial Results Conference Call on Friday, March 29, 2019 GlobeNewswire
Mar-04-19 08:30AM  Celsion Announces GEN-1 Data Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium GlobeNewswire
Feb-21-19 04:30PM  Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Feb-01-19 07:30AM  Consolidated Research: 2019 Summary Expectations for Southwest Airlines, Southern Copper, SEI Investments, Forward Air, Cincinnati Financial, and Celsion Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-24-19 11:30AM  Celsion Corporation to Present at NobleConXV Noble Capital Markets 15th Annual Investor Conference GlobeNewswire
Jan-17-19 08:30AM  Celsion Announces Publication of ThermoDox® Study Results in Radiology GlobeNewswire +8.49%
Jan-15-19 08:30AM  Celsion Announces Presentation of GEN-1 Data at Upcoming ASCO-SITC Clinical Immuno-Oncology Symposium GlobeNewswire +6.22%
Dec-25-18 02:47PM  Edited Transcript of CLSN earnings conference call or presentation 15-Nov-18 4:00pm GMT Thomson Reuters StreetEvents
Dec-18-18 08:00AM  Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsions Phase III OPTIMA Study of ThermoDox® for Treatment of Primary Liver Cancer GlobeNewswire -8.33%
Dec-03-18 09:15AM  Celsion Receives $11.1 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program GlobeNewswire
Nov-21-18 02:53PM  Analysts Take Action on Health Care Stocks GuruFocus.com
Nov-14-18 04:30PM  Celsion Corporation Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-08-18 09:15AM  Celsion Corporation to Hold Third Quarter 2018 Financial Results Conference Call on Thursday, November 15, 2018 GlobeNewswire
Oct-25-18 08:40AM  Report: Exploring Fundamental Drivers Behind The ExOne, Switch, Monotype Imaging, Celsion, TrueCar, and Sandstorm Gold New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-24-18 09:25AM  Celsion Announces Progression-Free Survival Data From GEN-1 Phase I Immuno-Oncology Study of Patients with Stage III/IV Ovarian Cancer GlobeNewswire
Oct-22-18 09:20AM  Celsion Announces Publication Highlighting the Potential of Celsion's Gene-Mediated Immunotherapy to Improve Administration of IL-12 and Progression-Free Survival in Ovarian Cancer Patients GlobeNewswire -8.43%
Oct-03-18 05:15PM  Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Sep-17-18 08:30AM  Celsion Appoints Marianne Lambertson as Vice President of Communications and Investor Relations GlobeNewswire
Sep-16-18 02:22PM  The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs Benzinga
Sep-06-18 08:00AM  Celsion Announces First Patient Randomized in the Gene-Mediated Immunotherapy (GEN-1) Study of Newly Diagnosed Stage III/IV Ovarian Cancer Patients GlobeNewswire
Sep-05-18 08:00AM  Celsion Announces Enrollment Completion for Pivotal Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer GlobeNewswire -6.42%
07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group New Research Emphasizes Economic Growth GlobeNewswire
Sep-04-18 08:30AM  Celsion Strengthens Its Balance Sheet with the Approval of Its Application to Sell Net Operating Losses for up to $10 Million in Non-Dilutive Funding GlobeNewswire
Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martinez Alberto R JrDirectorFeb 28Buy0.905,0004,50045,000Feb 28 10:50 AM
Martinez Alberto R JrDirectorNov 20Buy1.426,0008,52040,000Nov 20 11:28 AM
Fritz Frederick J.DirectorNov 06Buy1.3910,00013,87651,491Nov 07 08:33 AM
Martinez Alberto R JrDirectorNov 04Buy1.614,0006,44034,000Nov 04 02:40 PM
Fritz Frederick J.DirectorAug 02Buy1.7310,00017,30041,491Aug 02 04:09 PM
Martinez Alberto R JrDirectorJul 25Buy1.766,00010,56030,000Jul 25 01:27 PM
Fritz Frederick J.DirectorJul 24Buy1.7310,00017,30031,491Jul 25 09:15 AM
CHURCH JEFFREY WAYNECFOJun 19Buy1.895,0009,4507,298Jun 19 12:07 PM